查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1251988

醣生物学的全球市场:全球感染疾病的流行牵引市场需求

The Rising Prevalence of Infectious Diseases across the Globe Are Driving the Demand within the Glycobiology Market
出版日期: | 出版商: Persistence Market Research | 英文 246 Pages | 商品交期: 2-5个工作天内

价格

本报告提供全球醣生物学市场的相关调查，市场概要，市场分析，竞争分析等全面性资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类法
  • 市场定义/范围/限制
  • 蕴藏和除外

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新、开发趋势

第4章 主要成功因素

  • 产品采用、利用分析
  • 产品的USP/功能
  • 最近产品认证与发售
  • 大环境分析
  • 波特分析
  • 法规情境
  • 价值链分析

第5章 市场背景

  • 宏观经济要素
    • 全球GDP成长的展望
    • 全球医疗的展望
    • 全球酵素市场展望
  • 预测要素-相关性及影响
    • 老年人口增加
    • 透过政府机关的资金筹措
    • 技术的进步
    • 合併和收购
    • 醣生物学产品的成本
    • 先天性疾病的发生率增加
    • 高精度医疗开发的投资增加
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会分析

第6章 COVID-19危机-影响评估

  • COVID-19及影响分析
    • 各产品
    • 各酵素
    • 各用途
    • 各终端用户
    • 各地区
  • 市场情境(2023年)

第7章 全球市场的需求(金额或规模，100万美元)的分析与预测

  • 过去的市场分析
  • 现在及未来市场预测
    • 与前一年同期比较成长趋势分析

第8章 全球市场分析与预测:各产品

  • 简介/主要调查结果
  • 过去的市场分析:各产品
  • 现在及未来市场分析与预测:各产品
    • 设备
    • 酵素
    • 消耗品
    • 套件和试剂
  • 市场魅力分析:各产品

第9章 按全球市场的分析与预测:酵素

  • 简介/主要调查结果
  • 过去的市场分析:各酵素
  • 现在及未来市场分析与预测:各酵素
    • 半乳糖甘酶
    • GlcNAc转移酶
    • Fucosyltransferases
    • GalNAc转移酶
    • Galactosyl Transferases
    • Glucuronosyltransferases
    • Glucosyltransferases
    • Pentosyltransferases
    • 碳水化合物激酶
    • 神经胺糖酸酶
    • Sialyltransferases
    • 其他
  • 市场魅力分析:各酵素

第10章 全球市场分析与预测:各用途

  • 简介/主要调查结果
  • 过去的市场分析:各用途
  • 现在及未来市场分析与预测:各用途
    • 药物研发与开发
    • 对诊断的用途
    • 对工业的用途
    • 对治疗的用途
    • 其他
  • 市场魅力分析:各用途

第11章 全球市场分析与预测:各终端用户

  • 简介/主要调查结果
  • 过去的市场分析:各终端用户
  • 现在及未来市场分析与预测:各终端用户
    • 生物医药品企业
    • 研究
    • 医院
    • 诊断中心
    • 受託研究机构
    • 生物技术产业
    • 学术机构
    • 其他
  • 市场魅力分析:各终端用户

第12章 全球市场的分析与预测:各地区

  • 简介
  • 过去的市场分析:各地区
  • 现在及未来市场分析与预测:各地区
    • 北美
    • 南美
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东、非洲
  • 市场魅力分析:各地区

第13章 北美市场分析与预测

第14章 南美市场分析与预测

第15章 欧洲市场分析与预测

第16章 南亚市场分析与预测

第17章 东亚市场分析与预测

第18章 大洋洲市场分析与预测

第19章 中东及非洲市场分析与预测

第20章 市场结构分析

  • 市场分析:各企业层
  • 主要企业的市场占有率分析
  • 市场影响分析

第21章 竞争分析

  • 竞争仪表板
  • 品牌和推销策略
  • 主要开发分析
  • 竞争详细内容
    • Glycodiag
    • Tracxn Technologies Limited
    • Agilent Tecnologies, Inc.
    • Takara Bio Inc.
    • Bio-Techne
    • Bruker Corporation
    • Thermo Fisher Scientific Inc.
    • Shimadzu Corporation
    • New England Biolabs.
    • Waters.co.
    • Merck KGaA
    • Palleon Pharmaceuticals
    • Asparia Glycomics
    • RayBiotech Life,Inc.
    • Z Biotech,LLC.
    • Chemily Glycoscience
    • Lectenz Bio
    • 2BScientific

第22章 所使用的假设和缩写

第23章 调查手法

Product Code: PMRREP4769

Glycobiology Market: Scope of the Report

The latest publication by Persistence Market Research on the global glycobiology market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 - 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for glycobiology products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the glycobiology market. Shareholders in the glycobiology market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the glycobiology market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the glycobiology market offers information divided into five important segments - product, enzyme, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Instruments

Enzymes

Consumables

Kits and Reagents

Enzyme

Galactosidases

Fucosidases

Chitinases

Acetylgalactosaminidase

Heparinase

PNGase F

Others

GlcNAc Transferases

Acetylglucosaminyltransferase

Exostosin

Others

Fucosyltransferases

GalNAc Transferases

Galactosyl Transferases

Glucuronosyltransferases

Glucosyltransferases

Pentosyltransferases

Carbohydrate Kinases

Neuraminidases

Sialyltransferases

Others

Application

Drug Discovery and Development

Diagnostic Applications

Oncology

Immunology

Others

Industrial Applications

Therapeutic Applications

Oncology

Immunology

Others

Others

End User

Biopharmaceutical Companies

Research Laboratories

Hospitals

Diagnostic Centers

Contract Research Organizations

Biotechnology Industries

Academic Institutes

Others

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for glycobiology over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the glycobiology market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the glycobiology market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the glycobiology market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario
  • 4.7. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Enzymes Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Geriatric Population
    • 5.2.2. Funding Through Government Bodies
    • 5.2.3. Technological Advancements
    • 5.2.4. Mergers and Acquisitions
    • 5.2.5. Cost of Glycobiology Products
    • 5.2.6. Increasing Incidence of Congenital Disorders
    • 5.2.7. Growing Investments in Precision Medicine Development
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Enzyme
    • 6.1.3. By Application
    • 6.1.4. By End User
    • 6.1.5. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
    • 8.3.1. Instruments
    • 8.3.2. Enzymes
    • 8.3.3. Consumables
    • 8.3.4. Kits and Reagents
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Enzyme

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Enzyme, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Enzyme, 2023-2033
    • 9.3.1. Galactosidases
      • 9.3.1.1. Fucosidases
      • 9.3.1.2. Chitinases
      • 9.3.1.3. Acetylgalactosaminidase
      • 9.3.1.4. Heparinase
      • 9.3.1.5. PNGase F
      • 9.3.1.6. Others
    • 9.3.2. GlcNAc Transferases
      • 9.3.2.1. Acetylglucosaminyltransferase
      • 9.3.2.2. Exostosin
      • 9.3.2.3. Others
    • 9.3.3. Fucosyltransferases
    • 9.3.4. GalNAc Transferases
    • 9.3.5. Galactosyl Transferases
    • 9.3.6. Glucuronosyltransferases
    • 9.3.7. Glucosyltransferases
    • 9.3.8. Pentosyltransferases
    • 9.3.9. Carbohydrate Kinases
    • 9.3.10. Neuraminidases
    • 9.3.11. Sialyltransferases
    • 9.3.12. Others
  • 9.4. Market Attractiveness Analysis By Enzyme

10. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2023-2033
    • 10.3.1. Drug Discovery and Development
    • 10.3.2. Diagnostic Applications
      • 10.3.2.1. Oncology
      • 10.3.2.2. Immunology
      • 10.3.2.3. Others
    • 10.3.3. Industrial Applications
    • 10.3.4. Therapeutic Applications
      • 10.3.4.1. Oncology
      • 10.3.4.2. Immunology
      • 10.3.4.3. Others
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2015-2022 and Forecast 2023-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023-2033
    • 11.3.1. Biopharmaceutical Companies
    • 11.3.2. Research Laboratories
    • 11.3.3. Hospitals
    • 11.3.4. Diagnostic Centres
    • 11.3.5. Contract Research Organizations
    • 11.3.6. Biotechnology Industries
    • 11.3.7. Academic Institutes
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2015-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Enzyme
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Enzyme
    • 13.4.4. By Application
    • 13.4.5. By End User
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. U.S. Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Enzyme
        • 13.5.1.2.3. By Application
        • 13.5.1.2.4. By End User
    • 13.5.2. Canada Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Enzyme
        • 13.5.2.2.3. By Application
        • 13.5.2.2.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Latin America Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Enzyme
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Enzyme
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. Brazil Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Enzyme
        • 14.5.1.2.3. By Application
        • 14.5.1.2.4. By End User
    • 14.5.2. Mexico Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Enzyme
        • 14.5.2.2.3. By Application
        • 14.5.2.2.4. By End User
    • 14.5.3. Argentina Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Enzyme
        • 14.5.3.2.3. By Application
        • 14.5.3.2.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Europe Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Italy
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. Russia
      • 15.3.1.7. BENELUX
      • 15.3.1.8. Nordic Countries
      • 15.3.1.9. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Enzyme
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Enzyme
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Germany Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Enzyme
        • 15.5.1.2.3. By Application
        • 15.5.1.2.4. By End User
    • 15.5.2. France Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Enzyme
        • 15.5.2.2.3. By Application
        • 15.5.2.2.4. By End User
    • 15.5.3. Italy Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Enzyme
        • 15.5.3.2.3. By Application
        • 15.5.3.2.4. By End User
    • 15.5.4. U.K. Market Analysis
      • 15.5.4.1. Introduction
      • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.4.2.1. By Product
        • 15.5.4.2.2. By Enzyme
        • 15.5.4.2.3. By Application
        • 15.5.4.2.4. By End User
    • 15.5.5. Spain Market Analysis
      • 15.5.5.1. Introduction
      • 15.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.5.2.1. By Product
        • 15.5.5.2.2. By Enzyme
        • 15.5.5.2.3. By Application
        • 15.5.5.2.4. By End User
    • 15.5.6. Russia Market Analysis
      • 15.5.6.1. Introduction
      • 15.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.6.2.1. By Product
        • 15.5.6.2.2. By Enzyme
        • 15.5.6.2.3. By Application
        • 15.5.6.2.4. By End User
    • 15.5.7. Nordic Countries Market Analysis
      • 15.5.7.1. Introduction
      • 15.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.7.2.1. By Product
        • 15.5.7.2.2. By Enzyme
        • 15.5.7.2.3. By Application
        • 15.5.7.2.4. By End User
    • 15.5.8. BENELUX Market Analysis
      • 15.5.8.1. Introduction
      • 15.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.8.2.1. By Product
        • 15.5.8.2.2. By Enzyme
        • 15.5.8.2.3. By Application
        • 15.5.8.2.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. South Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Thailand
      • 16.3.1.3. Indonesia
      • 16.3.1.4. Malaysia
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Enzyme
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Enzyme
    • 16.4.4. By Application
    • 16.4.5. By End User
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. India Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Enzyme
        • 16.5.1.2.3. By Application
        • 16.5.1.2.4. By End User
    • 16.5.2. Thailand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Enzyme
        • 16.5.2.2.3. By Application
        • 16.5.2.2.4. By End User
    • 16.5.3. Indonesia Market Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product
        • 16.5.3.2.2. By Enzyme
        • 16.5.3.2.3. By Application
        • 16.5.3.2.4. By End User
    • 16.5.4. Malaysia Market Analysis
      • 16.5.4.1. Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product
        • 16.5.4.2.2. By Enzyme
        • 16.5.4.2.3. By Application
        • 16.5.4.2.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. East Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Enzyme
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Enzyme
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. China Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Enzyme
        • 17.5.1.2.3. By Application
        • 17.5.1.2.4. By End User
    • 17.5.2. Japan Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Enzyme
        • 17.5.2.2.3. By Application
        • 17.5.2.2.4. By End User
    • 17.5.3. South Korea Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Enzyme
        • 17.5.3.2.3. By Application
        • 17.5.3.2.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Oceania Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Enzyme
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Enzyme
    • 18.4.4. By Application
    • 18.4.5. By End User
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. Australia Market Analysis
      • 18.5.1.1. Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product
        • 18.5.1.2.2. By Enzyme
        • 18.5.1.2.3. By Application
        • 18.5.1.2.4. By End User
    • 18.5.2. New Zealand Market Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product
        • 18.5.2.2.2. By Enzyme
        • 18.5.2.2.3. By Application
        • 18.5.2.2.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Market Analysis 2015-2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Northern Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Enzyme
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Enzyme
    • 19.4.4. By Application
    • 19.4.5. By End User
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. GCC Countries Market Analysis
      • 19.5.1.1. Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product
        • 19.5.1.2.2. By Enzyme
        • 19.5.1.2.3. By Application
        • 19.5.1.2.4. By End User
    • 19.5.2. Turkiye Market Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product
        • 19.5.2.2.2. By Enzyme
        • 19.5.2.2.3. By Application
        • 19.5.2.2.4. By End User
    • 19.5.3. Northern Africa Market Analysis
      • 19.5.3.1. Introduction
      • 19.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.3.2.1. By Product
        • 19.5.3.2.2. By Enzyme
        • 19.5.3.2.3. By Application
        • 19.5.3.2.4. By End User
    • 19.5.4. South Africa Market Analysis
      • 19.5.4.1. Introduction
      • 19.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.4.2.1. By Product
        • 19.5.4.2.2. By Enzyme
        • 19.5.4.2.3. By Application
        • 19.5.4.2.4. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Branding and Promotional Strategies
  • 21.3. Key Development Analysis
  • 21.4. Competition Deep Dive
    • 21.4.1. Glycodiag
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Key Financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Strategy Overview
    • 21.4.2. Tracxn Technologies Limited
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Key Financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Strategy Overview
    • 21.4.3. Agilent Tecnologies, Inc.
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Key Financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Strategy Overview
    • 21.4.4. Takara Bio Inc.
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Key Financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Strategy Overview
    • 21.4.5. Bio-Techne
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Key Financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Strategy Overview
    • 21.4.6. Bruker Corporation
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Key Financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Strategy Overview
    • 21.4.7. Thermo Fisher Scientific Inc.
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Key Financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Strategy Overview
    • 21.4.8. Shimadzu Corporation
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Key Financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Strategy Overview
    • 21.4.9. New England Biolabs.
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Key Financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Strategy Overview
    • 21.4.10. Waters.co.
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Key Financials
      • 21.4.10.4. Sales Footprint
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Strategy Overview
    • 21.4.11. Merck KGaA
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Key Financials
      • 21.4.11.4. Sales Footprint
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Strategy Overview
    • 21.4.12. Palleon Pharmaceuticals
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Key Financials
      • 21.4.12.4. Sales Footprint
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Strategy Overview
    • 21.4.13. Asparia Glycomics
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Key Financials
      • 21.4.13.4. Sales Footprint
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Strategy Overview
    • 21.4.14. RayBiotech Life,Inc.
      • 21.4.14.1. Overview
      • 21.4.14.2. Product Portfolio
      • 21.4.14.3. Key Financials
      • 21.4.14.4. Sales Footprint
      • 21.4.14.5. SWOT Analysis
      • 21.4.14.6. Strategy Overview
    • 21.4.15. Z Biotech,LLC.
      • 21.4.15.1. Overview
      • 21.4.15.2. Product Portfolio
      • 21.4.15.3. Key Financials
      • 21.4.15.4. Sales Footprint
      • 21.4.15.5. SWOT Analysis
      • 21.4.15.6. Strategy Overview
    • 21.4.16. Chemily Glycoscience
      • 21.4.16.1. Overview
      • 21.4.16.2. Product Portfolio
      • 21.4.16.3. Key Financials
      • 21.4.16.4. Sales Footprint
      • 21.4.16.5. SWOT Analysis
      • 21.4.16.6. Strategy Overview
    • 21.4.17. Lectenz Bio
      • 21.4.17.1. Overview
      • 21.4.17.2. Product Portfolio
      • 21.4.17.3. Key Financials
      • 21.4.17.4. Sales Footprint
      • 21.4.17.5. SWOT Analysis
      • 21.4.17.6. Strategy Overview
    • 21.4.18. 2BScientific
      • 21.4.18.1. Overview
      • 21.4.18.2. Product Portfolio
      • 21.4.18.3. Key Financials
      • 21.4.18.4. Sales Footprint
      • 21.4.18.5. SWOT Analysis
      • 21.4.18.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

  • Table 01: Global Glycobiology Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Product
  • Table 02: Global Glycobiology Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Enzyme
  • Table 03: Global Glycobiology Market Size (US$ Mn) Analysis and Forecast 2023-2033, by Application
  • Table 04: Global Glycobiology Market Value (US$ Mn) Analysis- and Forecast 2023-2033, by End User
  • Table 05: North America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 06: North America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 07: North America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 08: North America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 09: North America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 10: Latin America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 11: Latin America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 12: Latin America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 13: Latin America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 14: Latin America Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 15: Europe Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 16: Europe Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 17: Europe Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 18: Europe Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 19: Europe Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 20: South Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 21: South Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 22: South Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 23: South Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 24: South Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 25: East Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 26: East Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 27: East Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 28: East Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 29: East Asia Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 30: Oceania Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 31: Oceania Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 32: Oceania Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 33: Oceania Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 34: Oceania Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User
  • Table 35: Middle East & Africa Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 36: Middle East & Africa Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 37: Middle East & Africa Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Enzyme
  • Table 38: Middle East & Africa Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 39: Middle East & Africa Glycobiology Market Size (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by End User

List of Figures

  • Figure 01: Global Glycobiology Market Value Analysis (US$ Mn), 2015 - 2022
  • Figure 02: Global Glycobiology Market Value Forecast (US$ Mn), 2023-2033
  • Figure 03: Global Glycobiology Market Absolute $ Opportunity, 2022-2033
  • Figure 04: Global Glycobiology Market Share Analysis (%), by Product, 2023 & 2033
  • Figure 05: Global Glycobiology Market Y-o-Y Analysis (%), by Product, 2023-2033
  • Figure 06: Global Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 07: Global Glycobiology Market Share Analysis (%), by Enzyme, 2023 & 2033
  • Figure 08: Global Glycobiology Market Y-o-Y Analysis (%), by Enzyme, 2023-2033
  • Figure 09: Global Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 10: Global Glycobiology Market Share Analysis (%), by Application, 2023 & 2033
  • Figure 11: Global Glycobiology Market Y-o-Y Analysis (%), by Application, 2023-2033
  • Figure 12: Global Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 13: Global Glycobiology Market Share Analysis (%), End User, 2023 & 2033
  • Figure 14: Global Glycobiology Market Y-o-Y Analysis (%), End User, 2023-2033
  • Figure 15: Global Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 16: North America Glycobiology Market Value Share by Product 2023 (E)
  • Figure 17: North America Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 18: North America Glycobiology Market Value Share by Application 2023 (E)
  • Figure 19: North America Glycobiology Market Value Share End User 2023 (E)
  • Figure 20: North America Glycobiology Market Value Share by Country 2023 (E)
  • Figure 21: North America Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 22: North America Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 23: North America Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 24: North America Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 25: North America Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 26: North America Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 27: North America Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 28: U.S. Market Value Proportion Analysis, 2022
  • Figure 29: U.S. Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 30: U.S. Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 31: U.S. Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 32: U.S. Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 33: Canada Market Value Proportion Analysis, 2022
  • Figure 34: Canada Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 35: Canada Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 36: Canada Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 37: Canada Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 38: Latin America Glycobiology Market Value Share by Product 2023 (E)
  • Figure 39: Latin America Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 40: Latin America Glycobiology Market Value Share by Application 2023 (E)
  • Figure 41: Latin America Glycobiology Market Value Share End User 2023 (E)
  • Figure 42: Latin America Glycobiology Market Value Share by Country 2023 (E)
  • Figure 43: Latin America Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 44: Latin America Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 45: Latin America Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 46: Latin America Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 47: Latin America Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 48: Latin America Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 49: Latin America Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 50: Brazil Market Value Proportion Analysis, 2022
  • Figure 51: Brazil Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 52: Brazil Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 53: Brazil Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 54: Brazil Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 55: Mexico Market Value Proportion Analysis, 2022
  • Figure 56: Mexico Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 57: Mexico Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 58: Mexico Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 59: Mexico Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 60: Argentina Market Value Proportion Analysis, 2022
  • Figure 61: Argentina Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 62: Argentina Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 63: Argentina Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 64: Argentina Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 65: Europe Glycobiology Market Value Share by Product 2023 (E)
  • Figure 66: Europe Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 67: Europe Glycobiology Market Value Share by Application 2023 (E)
  • Figure 68: Europe Glycobiology Market Value Share End User 2023 (E)
  • Figure 69: Europe Glycobiology Market Value Share by Country 2023 (E)
  • Figure 70: Europe Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 71: Europe Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 72: Europe Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 73: Europe Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 74: Europe Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 75: Europe Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 76: Europe Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 77: Italy Market Value Proportion Analysis, 2022
  • Figure 78: Italy Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 79: Italy Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 80: Italy Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 81: Italy Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 82: Germany Market Value Proportion Analysis, 2022
  • Figure 83: Germany Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 84: Germany Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 85: Germany Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 86: Germany Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 87: U.K. Market Value Proportion Analysis, 2022
  • Figure 88: U.K. Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 89: U.K. Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 90: U.K. Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 91: U.K. Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 92: France Market Value Proportion Analysis, 2022
  • Figure 93: France Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 94: France Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 95: France Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 96: France Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 97: Spain Market Value Proportion Analysis, 2022
  • Figure 98: Spain Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 99: Spain Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 100: Spain Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 101: Spain Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 102: BENELUX Market Value Proportion Analysis, 2022
  • Figure 103: BENELUX Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 104: BENELUX Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 105: BENELUX Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 106: BENELUX Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 107: Nordic Countries Market Value Proportion Analysis, 2022
  • Figure 108: Nordic Countries Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 109: Nordic Countries Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 110: Nordic Countries Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 111: Nordic Countries Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 112: Russia Market Value Proportion Analysis, 2022
  • Figure 113: Russia Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 114: Russia Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 115: Russia Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 116: Russia Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 117: South Asia Glycobiology Market Value Share by Product 2023 (E)
  • Figure 118: South Asia Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 119: South Asia Glycobiology Market Value Share by Application 2023 (E)
  • Figure 120: South Asia Glycobiology Market Value Share End User 2023 (E)
  • Figure 121: South Asia Glycobiology Market Value Share by Country 2023 (E)
  • Figure 122: South Asia Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 123: South Asia Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 124: South Asia Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 125: South Asia Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 126: South Asia Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 127: South Asia Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 128: South Asia Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 129: India Market Value Proportion Analysis, 2022
  • Figure 130: India Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 131: India Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 132: India Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 133: India Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 134: Thailand Market Value Proportion Analysis, 2022
  • Figure 135: Thailand Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 136: Thailand Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 137: Thailand Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 138: Thailand Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 139: Indonesia Market Value Proportion Analysis, 2022
  • Figure 140: Indonesia Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 141: Indonesia Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 142: Indonesia Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 143: Indonesia Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 144: Malaysia Market Value Proportion Analysis, 2022
  • Figure 145: Malaysia Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 146: Malaysia Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 147: Malaysia Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 148: Malaysia Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 149: East Asia Glycobiology Market Value Share by Product 2023 (E)
  • Figure 150: East Asia Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 151: East Asia Glycobiology Market Value Share by Application 2023 (E)
  • Figure 152: East Asia Glycobiology Market Value Share End User 2023 (E)
  • Figure 153: East Asia Glycobiology Market Value Share by Country 2023 (E)
  • Figure 154: East Asia Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 155: East Asia Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 156: East Asia Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 157: East Asia Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 158: East Asia Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 159: East Asia Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 160: East Asia Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 161: China Market Value Proportion Analysis, 2022
  • Figure 162: China Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 163: China Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 164: China Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 165: China Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 166: Japan Market Value Proportion Analysis, 2022
  • Figure 167: Japan Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 168: Japan Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 169: Japan Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 170: Japan Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 171: South Korea Market Value Proportion Analysis, 2022
  • Figure 172: South Korea Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 173: South Korea Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 174: South Korea Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 175: South Korea Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 176: Oceania Glycobiology Market Value Share by Product 2023 (E)
  • Figure 177: Oceania Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 178: Oceania Glycobiology Market Value Share by Application 2023 (E)
  • Figure 179: Oceania Glycobiology Market Value Share End User 2023 (E)
  • Figure 180: Oceania Glycobiology Market Value Share by Country 2023 (E)
  • Figure 181: Oceania Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 182: Oceania Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 183: Oceania Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 184: Oceania Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 185: Oceania Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 186: Oceania Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 187: Oceania Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 188: Australia Market Value Proportion Analysis, 2022
  • Figure 189: Australia Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 190: Australia Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 191: Australia Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 192: Australia Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 193: New Zealand Market Value Proportion Analysis, 2022
  • Figure 194: New Zealand Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 195: New Zealand Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 196: New Zealand Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 197: New Zealand Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 198: Middle East and Africa Glycobiology Market Value Share by Product 2023 (E)
  • Figure 199: Middle East and Africa Glycobiology Market Value Share by Enzyme 2023 (E)
  • Figure 200: Middle East and Africa Glycobiology Market Value Share by Application 2023 (E)
  • Figure 201: Middle East and Africa Glycobiology Market Value Share End User 2023 (E)
  • Figure 202: Middle East and Africa Glycobiology Market Value Share by Country 2023 (E)
  • Figure 203: Middle East and Africa Glycobiology Market Historical Market Size (US$ Mn) Analysis, 2015-2022
  • Figure 204: Middle East and Africa Glycobiology Market Current and Future Market Size (US$ Mn), 2022-2033 & Y-o-Y Growth Trend Analysis
  • Figure 205: Middle East and Africa Glycobiology Market Attractiveness Analysis by Product, 2023-2033
  • Figure 206: Middle East and Africa Glycobiology Market Attractiveness Analysis by Enzyme, 2023-2033
  • Figure 207: Middle East and Africa Glycobiology Market Attractiveness Analysis by Application, 2023-2033
  • Figure 208: Middle East and Africa Glycobiology Market Attractiveness Analysis End User, 2023-2033
  • Figure 209: Middle East and Africa Glycobiology Market Attractiveness Analysis by Country, 2023-2033
  • Figure 210: GCC Countries Market Value Proportion Analysis, 2022
  • Figure 211: GCC Countries Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 212: GCC Countries Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 213: GCC Countries Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 214: GCC Countries Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 215: South Africa Market Value Proportion Analysis, 2022
  • Figure 216: South Africa Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 217: South Africa Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 218: South Africa Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 219: South Africa Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 220: North Africa Market Value Proportion Analysis, 2022
  • Figure 221: North Africa Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 222: North Africa Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 223: North Africa Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 224: North Africa Glycobiology Market Share Analysis (%), End User, 2022 & 2033
  • Figure 225: Turkiye Market Value Proportion Analysis, 2022
  • Figure 226: Turkiye Glycobiology Market Share Analysis (%), by Product, 2022 & 2033
  • Figure 227: Turkiye Glycobiology Market Share Analysis (%), by Enzyme, 2022 & 2033
  • Figure 228: Turkiye Glycobiology Market Share Analysis (%), by Application, 2022 & 2033
  • Figure 229: Turkiye Glycobiology Market Share Analysis (%), End User, 2022 & 2033